United States General Surgical Devices Market

United States General Surgical Devices Market Overview:

The United States general surgical devices market is projected to exhibit a growth rate (CAGR) of 6.30% during 2024-2032. The market is expanding due to an increased demand for advanced surgical technologies like minimally invasive and robotic assisted procedures. Innovations in surgical instruments and imaging technologies are driving the market toward growth further, thereby improving precision and outcomes and enhancing efficiency in surgical settings.

United States General Surgical Devices Market Trends:

Growth of Minimally Invasive Surgery

The growth of minimally invasive surgery is transforming the healthcare landscape as patients nowadays increasingly prefer procedures that offer quicker recovery, less pain and minimal scarring. This shift is fueled by the advancements in technology such as laparoscopic tools, endoscopic devices and robotic systems which allows surgeons to perform complex operations with smaller incisions. These innovations reduce the risk of infection and shorten the hospital stays, thus further contributing to their rising popularity. The demand for minimally invasive surgery has consequently driven the development of specialized surgical instruments and equipment, which, in turn, is expanding the market for these advanced medical devices. For instance, in November 2023, Cleveland Clinic became the first medical center in the United States to successfully perform a minimally invasive gastric sleeve procedure using a newly FDA-approved surgery robot with magnetic technology. This advancement in robotic technology is enhancing minimally invasive surgery allowing for fewer incisions, reduced pain and quicker recovery for patients. Magnetic technology enables surgeons to manipulate tissue and organs gently as needed during surgery providing numerous benefits for both patients and surgeons.

Technological Advancements

Technological advancements in surgical devices are revolutionizing the field of surgery with innovations like robotic assisted systems, laparoscopic instruments and enhanced imaging technologies. Robotic surgery systems offer unparalleled precision by providing surgeons with better control and flexibility which helps minimize errors and improve outcomes. Laparoscopic instruments are designed for minimally invasive procedures allows for smaller incisions, reduced recovery time and fewer complications. Enhanced imaging technologies such as 3D and real-time imaging enable more accurate diagnoses and precise surgical planning. These innovations collectively enhance patient safety optimize surgical performance and contribute to the growing popularity of advanced surgical technologies in healthcare settings. For instance, in February 2024, US FDA granted authorization to Virtual Incision Corporation for the MIRA Surgical System, the world's first miniaturized robotic-assisted surgery device. It is authorized for use in adults undergoing colectomy procedures. The compact and portable design of MIRA could potentially overcome challenges associated with existing mainframe surgical robots and expand access to robotic-assisted surgery. Virtual Incision plans to begin the commercialization in the United States and expand to additional sites over time with future indications including gynecology, general surgery, urology and other soft tissue and solid organ surgery.

United States General Surgical Devices Market News:

• In August 2024, CooperCompanies acquired OBP Surgical, a U.S. based medical device company for approximately $100 million. The acquired products generated around $14.5 million in revenue in the past year. The acquisition is expected to be neutral to Cooper’s non-GAAP earnings per share in fiscal 2024 and accretive thereafter. The acquisition integrates OBP Surgical’s products, including ONETRAC surgical retractors and suction devices, into CooperSurgical’s portfolio, thus further expanding their offering of innovative surgical technologies.
• In June 2023, BD (Becton, Dickinson, and Company) signed an agreement to sell its Surgical Instrumentation platform to STERIS for $540 million. The divestiture includes V. Mueller, Snowden-Pencer, and Genesis branded products, as well as three manufacturing facilities. Approximately 360 employees will transfer to STERIS. This move aligns with BD's strategy to simplify its portfolio and focus on higher-growth markets. The transaction is expected to close within BD's fiscal year 2023, pending regulatory approval.
   

United States General Surgical Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product and application.

Product Insights:

• Handheld Devices
• Laparoscopic Devices
• Electro Surgical Devices
• Wound Closure Devices
• Trocars and Access Devices
• Others
   

The report has provided a detailed breakup and analysis of the market based on the product. This includes handheld devices, laparoscopic devices, electro surgical devices, wound closure devices, trocars and access devices, and others.

Application Insights:

• Gynecology and Urology
• Cardiology
• Orthopedic
• Neurology
• Others
   

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes gynecology and urology, cardiology, orthopedic, neurology, and others.

Regional Insights:

• Northeast
• Midwest
• South
• West
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States General Surgical Devices Market Report Coverage:

Key Questions Answered in This Report:

• How has the United States general surgical devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the United States general surgical devices market?
• What is the breakup of the United States general surgical devices market on the basis of product?
• What is the breakup of the United States general surgical devices market on the basis of application?
• What are the various stages in the value chain of the United States general surgical devices market? 
• What are the key driving factors and challenges in the United States general surgical devices?
• What is the structure of the United States general surgical devices market and who are the key players?
• What is the degree of competition in the United States general surgical devices market? 

 Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States general surgical devices market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States general surgical devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States general surgical devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.